Results 151 to 160 of about 816,942 (315)

Informing prostate cancer screening policy makers in the European Union: lessons from cancer screening governance and policymaking. [PDF]

open access: yesEur J Public Health
Collen S   +6 more
europepmc   +1 more source

Mass screening for cancer of the cervix uteri in Fukushima Prefecture

open access: bronze, 1976
Takeshi Tomita   +4 more
openalex   +2 more sources

Breast cancer screening legislation in the United States. [PDF]

open access: bronze, 1989
Grey B. Thompson   +2 more
openalex   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

open access: yesMolecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton   +17 more
wiley   +1 more source

The results of mass screening of cervical cancer and its management at AMHTS of Tokai Univercity Hospital

open access: bronze, 1978
篠塚 孝男   +5 more
openalex   +2 more sources

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

open access: yesMolecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop   +10 more
wiley   +1 more source

Colorectal cancer screening. [PDF]

open access: yesSingapore Med J
Ang TL.
europepmc   +1 more source

Home - About - Disclaimer - Privacy